Postpartum Hemorrhage: all 456 studies

Page 5 of 5. Open to participants first (77), then studies with results posted, then the rest; newest registration first within each.

• Carbetocin at Cesarean Delivery for Labor ArrestCompletedNCT01725243Not applicable
• Comparing Misoprostol and Oxytocin in Uniject for Postpartum Hemorrhage (PPH) Prevention in SenegalCompletedNCT01713153Not applicable
• Misoprostol and Oxytocin in Uniject® for Postpartum Hemorrhage Prevention in CommunitiesWithdrawnNCT01710566Phase 3
• HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI DeficiencyNo longer availableNCT01701947
• In Vitro Myometrial Contractions in Laboring and Non-laboring WomenCompletedNCT01689311Not applicable
• Carbetocin vs. Oxytocin: In-vitro Myometrial Contractions With and Without Oxytocin Pre-treatmentCompletedNCT01689298Not applicable
• Assessing Childbirth-related Complications at the Community Level in KenyaCompletedNCT01665456
• Carbetocin at Elective Cesarean Delivery Part 3CompletedNCT01651130Not applicable
• Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean SectionCompletedNCT01630187Phase 4
• Misoprostol for Treatment of Postpartum Hemorrhage at Community-level Births in EgyptCompletedNCT01619072Not applicable
• Comparison of Sublingual Misoprostol and Intravenous Oxytocin in Active Management of the Third Stage of LaborStatus unknownNCT01612390
• IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum HemorrhageCompletedNCT01608958Not applicable
• Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized TrialStatus unknownNCT01600612Not applicable
• Can Tranexamic Acid Reduce Bleeding After Post Partum Hemorrhage in Cesarean Section DeliveryCompletedNCT01599468Phase 4
• ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean DeliveryStatus unknownNCT01579201Phase 4
• Evaluation of Melatonin's Effect on Pain and Blood Loss After Cesarean SectionCompletedNCT01572805Phase 1/2
• Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean SectionCompletedNCT01571323Phase 1/2
• A Study of Self-administered Misoprostol to Prevent Bleeding After Childbirth in the Community (MamaMiso)CompletedNCT01510574Not applicable
• Misoprostol for Treatment of Postpartum Haemorrhage (PPH) in Home BirthsCompletedNCT01508429Not applicable
• Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in MaliWithdrawnNCT01487278Not applicable
• Treatment of Postpartum Haemorrhage (PPH) Using Misoprostol in Home BirthsCompletedNCT01485562Not applicable
• Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE)CompletedNCT01480544Not applicable
• Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in IndiaCompletedNCT01462422Not applicable
• Carbetocin at Elective Cesarean Delivery Part 2CompletedNCT01428817Not applicable
• Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe PreeclampsiaStatus unknownNCT01382732Phase 3
• Hemcon© Bandage for Postpartum Bleeding Due to the Multiple Vaginal LacerationsStatus unknownNCT01373801Not applicable
• Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or OxytocinCompletedNCT01373359Phase 3
• Balloon Catheters in Cases of Abnormal PlacentationCompletedNCT01373255Not applicable
• Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled TrialCompletedNCT01359878Phase 2/3
• Emergency Peripartum Hysterectomy: A Prospective Study in IranCompletedNCT01285258Phase 2
• Carbetocin at Elective Cesarean DeliveryCompletedNCT01262742Not applicable
• Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery?WithdrawnNCT01252342Phase 4
• Oxytocin in Cesarean DeliveryStatus unknownNCT01236482Phase 4
• Postpartum Oxygen Inhalation for the Treatment of Postpartum HaemorrhageStatus unknownNCT01180192Phase 4
• Intrarectal Misoprostol in Postpartum HaemorrhageCompletedNCT01116050Phase 3
• Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum HaemorrhageTerminatedNCT01113229Phase 4
• Non-Invasive Measurement of Hemoglobin (Using Pulse Co-Oximetry) in Patients Undergoing Elective Cesarean DeliveryCompletedNCT01108471
• Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in IndiaWithdrawnNCT01108302Not applicable
• Effect of Prophylactic Administration of Oxytocin in Uniject™ on Postpartum Hemorrhage at Home Births in GhanaCompletedNCT01108289Not applicable
• Fever After Misoprostol Administration for the Treatment of Primary Postpartum HemorrhageCompletedNCT01080846Not applicable
• Prevention of Post-partum HaemorrhageCompletedNCT01044082Not applicable
• Impact of Uterotonic Agents on Isolated Human MyometriumCompletedNCT00989027Not applicable
• Haemorrhagia Postpartum: an Implementation Study on the NVOG Guidelines and MOET InstructionsStatus unknownNCT00928863
• World Maternal Antifibrinolytic TrialCompletedNCT00872469Phase 3
• Controlled Cord Traction During Third Stage of LaborCompletedNCT00781066Phase 3
• Carbetocin Versus Syntometrine for the Third Stage of LabourCompletedNCT00499005Phase 4
• Active Versus Expectant Management of the Third Stage of LaborCompletedNCT00473707Not applicable
• rhuFVIIa in Post-partum HemorrhageCompletedNCT00370877Phase 4
• Severe Post Partum Haemorrhage (PPH): A Randomized Trial on Transversal Intervention in 6 French Perinatal NetworksStatus unknownNCT00344929
• Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section?CompletedNCT00257803Not applicable
• Misoprostol for Preventing Postpartum HemorrhageCompletedNCT00124540Not applicable
• Misoprostol for the Prevention of Postpartum Hemorrhage in Rural PakistanCompletedNCT00120237Not applicable
• Misoprostol in the Treatment of Postpartum HemorrhageCompletedNCT00116480Not applicable
• Misoprostol for the Treatment of Postpartum HemorrhageCompletedNCT00116350Not applicable
• Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-scheduled Cesarean SectionCompletedNCT00107874Phase 2
• RCT of Misoprostol for Postpartum Hemorrhage in IndiaCompletedNCT00097123Not applicable

← Postpartum Hemorrhage overview